[Diabetes mellitus and osteoporosis: Who should be addressed and how to confirm the diagnosis].

MMW Fortschr Med

, Salinenstraße 8, D-83435, Bad Reichenhall, Deutschland.

Published: December 2018

Download full-text PDF

Source
http://dx.doi.org/10.1007/s15006-018-1239-9DOI Listing

Publication Analysis

Top Keywords

[diabetes mellitus
4
mellitus osteoporosis
4
osteoporosis addressed
4
addressed confirm
4
confirm diagnosis]
4
[diabetes
1
osteoporosis
1
addressed
1
confirm
1
diagnosis]
1

Similar Publications

Effects of Tinospora cordifolia (giloy) on metabolic syndrome components: a mechanistic review.

Naunyn Schmiedebergs Arch Pharmacol

December 2024

Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Metabolic syndrome is a cluster of some conditions such as high blood sugar, high blood triglycerides, low HDL cholesterol, abdominal obesity, and high blood pressure. Introducing a drug or a food that manages the majority of these medical conditions is invaluable. Tinospora cordifolia, known as guduchi and giloy, is a medicinal herb in ayurvedic medicine that is used in the treatment of various diseased conditions and also as a food for the maintenance of health.

View Article and Find Full Text PDF

Glimepiride (GLM) is one of the potential antidiabetic drugs used in clinics for a long time. It is currently used in combination with metformin along with other drugs, but has shown various complications in patients from long-term use. Thus, the hypothesis is to use a lower dose of GLM with a non-toxic class of flavonoid, naringin (NARN), for better therapy with minimal side-effects.

View Article and Find Full Text PDF

This article reviews the critical issue of diabetic retinopathy (DR) in pregnant women with diabetes mellitus (DM), and describes the current understanding of the features of DM progression during pregnancy, as well as its pathogenic mechanisms, risk factors, and preventive measures for manifestation and progression of DR during gestation.

View Article and Find Full Text PDF

The introduction of faricimab, a drug targeting both vascular endothelial growth factor-A (VEGF-A) and angiopoietin-2, has enabled the implementation of the highly effective dual inhibition strategy in real clinical practice for patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), both previously treated with intravitreal injections and newly diagnosed. This article presents a series of 11 clinical cases involving patients with nAMD and DME who received loading doses of faricimab and continued ophthalmological observation. Among them, three patients with nAMD and two with DME were treatment-naïve, while the others were switched from alternative therapies to faricimab.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!